The Institute of Scientific and Industrial Research, Osaka University, 8-1 Mihogaoka, Ibaraki, Osaka, 567-0047, Japan.
Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, 2-2 Yamada, Suita, Osaka, 565-0871, Japan.
Sci Rep. 2019 Mar 7;9(1):3886. doi: 10.1038/s41598-019-40504-x.
Identifying positions at which anticancer drug molecules incorporate into DNA is essential to define mechanisms underlying their activity, but current methodologies cannot yet achieve this. The thymidine fluorine substitution product trifluridine (FTD) is a DNA-damaging anticancer agent thought to incorporate into thymine positions in DNA. This mechanism, however, has not been directly confirmed. Here, we report a means to detect FTD in a single-stranded oligonucleotide using a method to distinguish single molecules by differences in electrical conductance. Entire sequences of 21-base single-stranded DNAs with and without incorporated drug were determined based on single-molecule conductances of the drug and four deoxynucleosides, the first direct observation of its kind. This methodology may foster rapid development of more effective anticancer drugs.
确定抗癌药物分子与 DNA 结合的位置对于确定其作用机制至关重要,但目前的方法还无法实现这一点。氟代胸苷三氟化物(FTD)是一种具有破坏 DNA 能力的抗癌药物,据认为它可以掺入 DNA 中的胸腺嘧啶位置。然而,这种机制尚未得到直接证实。在这里,我们报告了一种使用电导率差异来区分单分子的方法,在单链寡核苷酸中检测 FTD 的方法。基于药物和四种脱氧核苷酸的单分子电导率,确定了带有和不带有掺入药物的 21 个碱基的单链 DNA 的完整序列,这是首次进行这种直接观察。这种方法可能会促进更有效的抗癌药物的快速发展。